Modeling the critical MCOR-causing deletion in mouse unveils aberrant expression in developing and adult iris and ciliary body, and implicates in MCOR-associated glaucoma and myopia

Clémentine Angée,Elisa Erjavec,Djihad Hadjadj,Bruno Passet,Pierre David,Corinne Kostic,Emmanuel Dodé,Xavier Zanlonghi,Nicolas Cagnard,Brigitte Nedelec,Sylvain V. Crippa,Christine Bole-Feysot,Mohammed Zarhrate,Sophie Creuzet,Johan Castille,Jean-Luc Vilotte,Patrick Calvas,Julie Plaisancié,Nicolas Chassaing,Josseline Kaplan,Jean-Michel Rozet,Lucas Fares Taie
DOI: https://doi.org/10.1101/2023.12.11.571097
2024-01-17
Abstract:Congenital microcoria (MCOR) is a rare hereditary developmental defect of the iris dilator muscle, frequently associated with high axial myopia and high intraocular pressure (IOP) glaucoma. The condition is caused by submicroscopic rearrangements of chromosome 13q32.1. However, the mechanisms underlying the failure of iris development and the origin of associated features remain elusive. Here, we present a 3D architecture model of the 13q32.1 region, demonstrating that MCOR-related deletions consistently disrupt the boundary between two Topologically Associating Domains (TADs). Deleting the critical MCOR-causing region in mice reveals ectopic expression precisely aligning with , each located in one of the two neighbor TADs. This observation is consistent with the TADs’ boundary alteration and adoption of regulatory elements by the promoter. Additionally, we identify as a target gene of SOX21 and show TGFB2 accumulation in the aqueous humor of a MCOR-affected subject. Accumulation of TGFB2 is recognized for its role in glaucoma and potential impact on axial myopia. Our results highlight the importance of SOX21-TGFB2 signaling in iris development and control of eye growth and IOP. Insights from MCOR studies may provide therapeutic avenues for this condition but also for glaucoma and high myopia conditions, affecting millions of people.
Genetics
What problem does this paper attempt to address?